Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Inventory: 2009-2024

Historic Inventory for Fresenius Medical Care AG (FMS) over the last 17 years, with Sep 2025 value amounting to $2.4 billion.

  • Fresenius Medical Care AG's Inventory rose 18051.92% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 18051.92%. This contributed to the annual value of $2.2 billion for FY2024, which is 6.26% down from last year.
  • Fresenius Medical Care AG's Inventory amounted to $2.4 billion in Q3 2025, which was up 2,590.97% from -$97.9 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Inventory registered a high of $2.4 billion during Q3 2025, and its lowest value of -$181.2 million during Q3 2021.
  • In the last 3 years, Fresenius Medical Care AG's Inventory had a median value of -$44.5 million in 2024 and averaged $792.2 million.
  • Over the last 5 years, Fresenius Medical Care AG's Inventory had its largest YoY gain of 18,051.92% in 2025, and its largest YoY loss of 61.93% in 2025.
  • Fresenius Medical Care AG's Inventory (MRQ) stood at $2.3 billion in 2021, then rose by 0.48% to $2.3 billion in 2022, then increased by 0.08% to $2.3 billion in 2023, then dropped by 5.75% to $2.2 billion in 2024, then grew by 10.38% to $2.4 billion in 2025.
  • Its Inventory was $2.4 billion in Q3 2025, compared to -$97.9 million in Q2 2025 and $2.2 billion in Q1 2025.